{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:19:59Z","timestamp":1790054399279,"version":"4.0.1"},"reference-count":103,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.autrev.2017.05.004","type":"journal-article","created":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T06:33:05Z","timestamp":1493879585000},"page":"675-683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["New insights into the pathogenesis of giant cell arteritis"],"prefix":"10.1016","volume":"16","author":[{"given":"Francesco","family":"Ciccia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aroldo","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Ferrante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Guggino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Croci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Cavazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Salvarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Triolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2017.05.004_bb0005","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.1780380311","article-title":"Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970\u20131991","volume":"38","author":"Salvarani","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.004_bb0010","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0307-742X(21)00303-9","article-title":"Clinical manifestations of giant cell (temporal) arteritis","volume":"6","author":"Calamia","year":"1980","journal-title":"Clin Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.004_bb0015","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.004_bb0020","first-page":"1","article-title":"2016 ACR revised criteria for early diagnosis of giant cell (temporal) arteritis","volume":"3","author":"Salehi-Abari","year":"2016","journal-title":"Autoimmune Dis Ther Approaches"},{"key":"10.1016\/j.autrev.2017.05.004_bb0025","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1002\/1529-0131(199912)42:12<2674::AID-ANR25>3.0.CO;2-A","article-title":"Temporal artery biopsy: a diagnostic tool for systemic necrotizing vasculitis. French vasculitis study group","volume":"42","author":"Genereau","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.004_bb0030","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1097\/PAS.0000000000000244","article-title":"Inflamed temporal artery: histologic findings in 354 biopsies, with clinical correlations","volume":"38","author":"Cavazza","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.autrev.2017.05.004_bb0035","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002368","article-title":"Description and validation of histological patterns and proposal of a dynamic model of inflammatory infiltration in giant-cell arteritis","volume":"95","author":"Hern\u00e1ndez-Rodr\u00edguez","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2017.05.004_bb0040","first-page":"278","article-title":"Spectrum of aging changes in temporal arteries. Its significance, in interpretation of biopsy of temporal artery","volume":"90","author":"Lie","year":"1970","journal-title":"Arch Pathol"},{"key":"10.1016\/j.autrev.2017.05.004_bb0045","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0889-857X(21)00483-X","article-title":"Giant cell arteritis as an antigen-driven disease","volume":"21","author":"Weyand","year":"1995","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2017.05.004_bb0050","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2013.161","article-title":"Immune mechanisms in medium and large-vessel vasculitis","volume":"9","author":"Weyand","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.004_bb0055","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/1529-0131(199906)42:6<1255::AID-ANR23>3.0.CO;2-P","article-title":"The role of parvovirus B19 in the pathogenesis of giant cell arteritis: a preliminary evaluation","volume":"42","author":"Gabriel","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.004_bb0060","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/1529-0131(200106)44:6<1387::AID-ART232>3.0.CO;2-B","article-title":"Small-vessel vasculitis surrounding a spared temporal artery: clinical and pathological findings in a series of twenty-eight patients","volume":"44","author":"Esteban","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.004_bb0065","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/art.33362","article-title":"Small-vessel vasculitis surrounding an uninflamed temporal artery and isolated vasa vasorum vasculitis of the temporal artery: two subsets of giant cellarteritis","volume":"64","author":"Restuccia","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.004_bb0070","article-title":"Do solar cycles influence giant cell arteritis and rheumatoid arthritis incidence?","volume":"15","author":"Wing","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.autrev.2017.05.004_bb0075","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/rheumatology\/38.12.1208","article-title":"The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations","volume":"38","author":"Petursdottir","year":"1999","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2017.05.004_bb0080","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/1529-0131(200007)43:7<1543::AID-ANR19>3.0.CO;2-8","article-title":"Detection of Chlamydia pneumoniae in giant cell vasculitis and correlation with the topographic arrangement of tissue-infiltrating dendritic cells","volume":"43","author":"Wagner","year":"2000","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.004_bb0085","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4081\/reumatismo.2013.36","article-title":"Giant cell arteritis associated with chronic active Epstein\u2013Barr virus infection","volume":"65","author":"Giardina","year":"2013","journal-title":"Reumatismo"},{"key":"10.1016\/j.autrev.2017.05.004_bb0090","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/jamaneurol.2015.2101","article-title":"Analysis of Varicella-zoster virus in temporal arteries biopsy positive and negative for giant cell arteritis","volume":"72","author":"Nagel","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.autrev.2017.05.004_bb0095","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11910-015-0614-5","article-title":"Developments in Varicella zoster virus vasculopathy","volume":"16","author":"Nagel","year":"2016","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.autrev.2017.05.004_bb0100","doi-asserted-by":"crossref","first-page":"10527","DOI":"10.1128\/JVI.01546-16","article-title":"Varicella-zoster virus downregulates programmed death ligand 1 and major histocompatibility complex class I in human brain vascular adventitial fibroblasts, perineurial cells, and lung fibroblasts","volume":"90","author":"Jones","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.autrev.2017.05.004_bb0105","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.yexmp.2015.12.007","article-title":"VZV, temporal arteritis, and clinical practice: false positive immunohistochemical detection due to antibody cross-reactivity","volume":"100","author":"Pisapia","year":"2016","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.autrev.2017.05.004_bb0110","first-page":"210152","article-title":"Infections and the risk of incident giant cell arteritis: a population-based, case-control study","volume":"28","author":"Rhee","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.004_bb0115","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/rheumatology\/ket231","article-title":"Genetic component of giant cell arteritis","volume":"53","author":"Carmona","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2017.05.004_bb0120","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/rheumatology\/kel324","article-title":"Contribution of MHC class I region to genetic susceptibility for giant cell arteritis","volume":"46","author":"Gonzalez-Gay","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2017.05.004_bb0125","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1172\/JCI116125","article-title":"The HLA-DRB1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule","volume":"90","author":"Weyand","year":"1992","journal-title":"J Clin Invest"},{"issue":"17","key":"10.1016\/j.autrev.2017.05.004_bb0130","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13075-015-0692-4","article-title":"Association of HLA-DRB1 amino acid residues with giant cell arteritis: genetic association study, meta-analysis and geo-epidemiological investigation","volume":"30","author":"Mackie","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2017.05.004_bb0135","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ajhg.2015.02.009","article-title":"A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility","volume":"96","author":"Carmona","year":"2015","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.autrev.2017.05.004_bb0140","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00005792-200009000-00001","article-title":"Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161patients","volume":"79","author":"Gonz\u00e1lez-Gay","year":"2000","journal-title":"Medicine"},{"key":"10.1016\/j.autrev.2017.05.004_bb0145","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/ard.57.6.380","article-title":"Relation between HLA DRB1 alleles and corticosteroid resistance in giant cell arteritis","volume":"57","author":"Rauzy","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.004_bb0150","first-page":"17","article-title":"Association of HLA-DRB1 amino acid residues with giant cell arteritis: genetic association study, meta-analysis and geo-epidemiological investigation","volume":"30","author":"Mackie","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2017.05.004_bb0155","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2016-000246","article-title":"PTPN22 R620W minor allele is a genetic risk factor for giant cell arteritis","volume":"2","author":"Lester","year":"2016","journal-title":"RMD Open"},{"key":"10.1016\/j.autrev.2017.05.004_bb0160","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ajhg.2016.11.013","article-title":"A genome-wide association study identifies risk alleles in plasminogen and P4HA2 associated with giant cell arteritis","volume":"100","author":"Carmona","year":"2017","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.autrev.2017.05.004_bb0165","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1136\/annrheumdis-2014-207116","article-title":"DNA methylation analysis of the temporal artery microenvironment in giant cell arteritis","volume":"75","author":"Coit","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.004_bb0170","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/1529-0131(200008)43:8<1749::AID-ANR11>3.0.CO;2-K","article-title":"Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms","volume":"43","author":"Mattey","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.004_bb0175","first-page":"S18","article-title":"Interferon-gamma gene microsatellite polymorphisms in patients with biopsy-proven giant cell arteritis and isolated polymyalgia rheumatica","volume":"22","author":"Gonzalez-Gay","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.004_bb0180","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1002\/art.22218","article-title":"Interleukin-10 promoter polymorphisms in giant cell arteritis","volume":"54","author":"Boiardi","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.004_bb0185","first-page":"2413","article-title":"Epistatic interactions between HLA-DRB1 and interleukin 4, but not interferon-gamma, increase susceptibility to giant cell arteritis","volume":"31","author":"Amoli","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.004_bb0190","first-page":"2173","article-title":"Interleukin-6 promoter polymorphism at position \u2212174 in giant cell arteritis","volume":"32","author":"Salvarani","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.004_bb0195","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1136\/annrheumdis-2014-205261","article-title":"Influence of the IL17A locus in giant cell arteritis susceptibility","volume":"73","author":"M\u00e1rquez","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.004_bb0200","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1186\/ar2962","article-title":"Association between IL-18 gene polymorphisms and biopsy-proven giant cell arteritis","volume":"12","author":"Palomino-Morales","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2017.05.004_bb0205","first-page":"S12","article-title":"Role of the rs6822844 gene polymorphism at the IL2-IL21 region in biopsy-proven giant cell arteritis","volume":"29","author":"Rodr\u00edguez-Rodr\u00edguez","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.004_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113476","article-title":"A candidate gene approach identifies an IL33 genetic variant as a novel genetic risk factor for GCA","volume":"9","author":"M\u00e1rquez","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2017.05.004_bb0215","first-page":"507","article-title":"MCP-1 gene haplotype association in biopsy proven giant cell arteritis","volume":"32","author":"Amoli","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.004_bb0220","first-page":"391","article-title":"RANTES gene polymorphism in polymyalgia rheumatica, giant cell arteritis and rheumatoid arthritis","volume":"18","author":"Makki","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.004_bb0225","first-page":"1215","article-title":"Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica\/giant cell arteritis: association with disease risk and severity","volume":"27","author":"Salvarani","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.004_bb0230","first-page":"2160","article-title":"Vascular endothelial growth factor gene polymorphisms in giant cell arteritis","volume":"30","author":"Boiardi","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.004_bb0235","first-page":"2178","article-title":"Association of a functional inducible nitric oxide synthase promoter variant with susceptibility to biopsy-proven giant cell arteritis","volume":"32","author":"Gonzalez-Gay","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.004_bb0240","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/art.23457","article-title":"Association of a nonsynonymous single-nucleotide polymorphism of matrix metalloproteinase 9 with giant cell arteritis","volume":"58","author":"Rodriguez-Pla","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.004_bb0245","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.autrev.2011.06.002","article-title":"Toll-like receptor 4 gene polymorphism and giant cell arteritis susceptibility: a cumulative meta-analysis","volume":"10","author":"Alvarez-Rodriguez","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.05.004_bb0250","doi-asserted-by":"crossref","first-page":"R109","DOI":"10.1186\/ar1996","article-title":"Association of FCGR2A and FCGR2A-FCGR3A haplotypes with susceptibility to giant cell arteritis","volume":"8","author":"Morgan","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2017.05.004_bb0255","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/ard.2007.074666","article-title":"\u2212463 G\/A myeloperoxidase promoter polymorphism in giant cell arteritis","volume":"67","author":"Salvarani","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.004_bb0260","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/rheumatology\/ket231","article-title":"Genetic component of giant cell arteritis","volume":"53","author":"Carmona","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2017.05.004_bb0265","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1136\/annrheumdis-2012-202609","article-title":"Evidence of association of the NLRP1 gene with giant cell arteritis","volume":"72","author":"Serrano","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.004_bb0270","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3109\/03009742.2012.704392","article-title":"Toll-like receptor 9 gene polymorphisms in polymyalgia rheumatica and giant cell arteritis","volume":"41","author":"Alvarez-Rodr\u00edguez","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.004_bb0275","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.immuni.2015.05.015","article-title":"Artery tertiary lymphoid organs control aorta immunity and protect against atherosclerosis via vascular smooth muscle cell lymphotoxin \u03b2 receptors","volume":"42","author":"Hu","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2017.05.004_bb0280","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nri3700","article-title":"Ectopic lymphoid-like structures in infection, cancer and autoimmunity","volume":"14","author":"Pitzalis","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2017.05.004_bb0285","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/annrheumdis-2016-209217","article-title":"Ectopic expression of CXCL13, BAFF, APRIL and LT-\u03b2 is associated with artery tertiary lymphoid organs in giant cell arteritis","volume":"76","author":"Ciccia","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.004_bb0290","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/1529-0131(200111)44:11<2633::AID-ART443>3.0.CO;2-9","article-title":"Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sj\u00f6gren's syndrome","volume":"44","author":"Amft","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.004_bb0295","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1164\/rccm.201208-1543OC","article-title":"CXCL13 production in B cells via toll-like receptor\/lymphotoxin receptor signaling is involved in lymphoid neogenesis in chronic obstructive pulmonary disease","volume":"187","author":"Litsiou","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2017.05.004_bb0300","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1136\/ard.2010.140194","article-title":"Expression and function of toll-like receptors in peripheral blood mononuclear cells of patients with polymyalgia rheumatica and giant cell arteritis","volume":"70","author":"\u00c1lvarez Rodr\u00edguez","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.004_bb0305","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1084\/jem.20030850","article-title":"Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis","volume":"199","author":"Ma-Krupa","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2017.05.004_bb0310","first-page":"185","article-title":"Dendritic cells co-localize with activated CD4+ T cells in giant cell arteritis","volume":"21","author":"Wagner","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.004_bb0315","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/eji.200535467","article-title":"Preferential production of the IL-12(p40)\/IL-23(p19) heterodimer by dendritic cells from human newborns","volume":"36","author":"VandenEijnden","year":"2006","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2017.05.004_bb0320","doi-asserted-by":"crossref","first-page":"16309","DOI":"10.1073\/pnas.0508237102","article-title":"IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism","volume":"102","author":"Netea","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.autrev.2017.05.004_bb0325","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bbrc.2014.06.111","article-title":"Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension","volume":"451","author":"Shao","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2017.05.004_bb0330","first-page":"131","article-title":"Interleukin-32: a cytokine and inducer of TNF\u03b1","volume":"22","author":"Kim","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2017.05.004_bb0335","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1073\/pnas.0813334106","article-title":"IL-32-dependent effects of IL-1\u03b2 on endothelial cell functions","volume":"106","author":"Nold-Petry","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.autrev.2017.05.004_bb0340","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/art.30374","article-title":"Expression of interleukin-32 in the inflamed arteries of patients with giant cell arteritis","volume":"63","author":"Ciccia","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.004_bb0345","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nri1648","article-title":"New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions","volume":"5","author":"Hunter","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2017.05.004_bb0350","doi-asserted-by":"crossref","first-page":"R129","DOI":"10.1186\/ar3067","article-title":"Effects of inflammatory cytokine IL-27 on the activation of fibroblast-like synoviocytes in rheumatoid arthritis","volume":"12","author":"Wong","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2017.05.004_bb0355","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrrheum.2011.53","article-title":"Interleukin-33 biology with potential insights into human diseases","volume":"7","author":"Palmer","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.004_bb0360","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/annrheumdis-2012-201309","article-title":"IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis","volume":"72","author":"Ciccia","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.004_bb0365","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1084\/jem.179.3.951","article-title":"Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes","volume":"179","author":"Weyand","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2017.05.004_bb0370","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nri.2015.18","article-title":"Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease","volume":"16","author":"DuPage","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2017.05.004_bb0375","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1161\/CIRCULATIONAHA.109.872903","article-title":"Th17 and Th1 T-cell responses in giant cell arteritis","volume":"121","author":"Deng","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2017.05.004_bb0380","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/BOR.0b013e32833ee946","article-title":"IFN-\u03b3 and IL-17: the two faces of T-cellpathology in giant cell arteritis","volume":"23","author":"Weyand","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.004_bb0385","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/rheumatology\/kev102","article-title":"Difference in the expression of IL-9 and IL-17 correlates with different histological pattern of vascular wall injury in giant cell arteritis","volume":"54","author":"Ciccia","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2017.05.004_bb0390","doi-asserted-by":"crossref","first-page":"SII28","DOI":"10.3949\/ccjm.69.Suppl_2.SII28","article-title":"Pathogenic mechanisms in giant cell arteritis","volume":"69","author":"Weyand","year":"2002","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.autrev.2017.05.004_bb0395","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1136\/annrheumdis-2012-201836","article-title":"Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis","volume":"72","author":"Esp\u00edgol-Frigol\u00e9","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.004_bb0400","doi-asserted-by":"crossref","first-page":"E970","DOI":"10.1073\/pnas.1616848114","article-title":"Immunoinhibitory checkpoint deficiency in medium and large vessel vasculitis","volume":"14","author":"Zhang","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.autrev.2017.05.004_bb0405","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nm.2106","article-title":"Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection","volume":"16","author":"Said","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2017.05.004_bb0410","article-title":"An expanded population of pathogenic regulatory T cells in giant cell arteritis is abrogated by IL-6 blockade therapy","volume":"7","author":"Miyabe","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.004_bb0415","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/nri2862","article-title":"Regulatory T cells: CD8+ TReg cells join the fold","volume":"10","author":"Leavy","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2017.05.004_bb0420","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/art.1780261005","article-title":"Immunohistologic and cytochemical studies of temporal arteritis","volume":"26","author":"Banks","year":"1983","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.004_bb0425","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/j.2326-5205.1989.tb00020.x","article-title":"Immunohistochemical analysis of lymphoid and macrophage cell subsets and their immunologic activation markers in temporal arteritis. Influence of corticosteroid treatment","volume":"32","author":"Cid","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.004_bb0430","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1006\/clin.1996.0078","article-title":"Clonally expanded CD8 T cells in patients with polymyalgia rheumatica and giant cell arteritis","volume":"79","author":"Martinez-Taboada","year":"1996","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.autrev.2017.05.004_bb0435","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaut.2016.05.008","article-title":"Involvement and prognosis value of CD8(+) T cells in giant cell arteritis","volume":"72","author":"Samson","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2017.05.004_bb0440","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1172\/JCI84181","article-title":"NADPH oxidase deficiency underlies dysfunction of aged CD8+ Tregs","volume":"126","author":"Wen","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2017.05.004_bb0445","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1365-2249.2002.01751.x","article-title":"Analysis of the B cell repertoire against autoantigens in patients with giant cell arteritis and polymyalgia rheumatica","volume":"127","author":"Schmits","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2017.05.004_bb0450","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/ard.46.6.468","article-title":"Isolation and analysis of immune complexes from sera of patients with polymyalgia rheumatica and giant cell arteritis","volume":"46","author":"Smith","year":"1987","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.004_bb0455","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1172\/JCI119477","article-title":"Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras","volume":"99","author":"Brack","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2017.05.004_bb0460","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMcp1214825","article-title":"Giant-cell arteritis and polymyalgia rheumatica","volume":"371","author":"Weyand","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2017.05.004_bb0465","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1002\/art.38625","article-title":"Disturbed B cell homeostasis in newly diagnosed giant cell arteritis and polymyalgia rheumatica","volume":"66","author":"van der Geest","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.004_bb0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/RHU.0b013e31823e2e35","article-title":"Giant cell arteritis in Mexican patients","volume":"18","author":"Alba","year":"2012","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.004_bb0475","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/path.1660","article-title":"Early recruitment of phagocytes contributes to the vascular inflammation of giant cell arteritis","volume":"204","author":"Foell","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.autrev.2017.05.004_bb0480","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/CIRCRESAHA.114.301374","article-title":"Investigational analysis reveals a potential role for neutrophils in giant-cell arteritis disease progression","volume":"114","author":"Nadkarni","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.autrev.2017.05.004_bb0485","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1002\/eji.201444546","article-title":"Mast cell activation: a complex interplay of positive and negative signalling pathways","volume":"44","author":"Sibilano","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2017.05.004_bb0490","first-page":"S63","article-title":"Mast cells associate with T-cells and neointimal microvessels in giant cell arteritis","volume":"26","author":"M\u00e4yr\u00e4np\u00e4\u00e4","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.004_bb0495","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ophtha.2009.07.043","article-title":"Increased tissue endothelin-1 and endothelin-B receptor expression in temporal arteries from patients with giant cell arteritis","volume":"117","author":"Dimitrijevic","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.autrev.2017.05.004_bb0500","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/1529-0131(200001)43:1<184::AID-ANR23>3.0.CO;2-N","article-title":"Cell adhesion molecules in the development of inflammatory infiltrates in giant cell arteritis: inflammation-induced angiogenesis as the preferential site of leukocyte-endothelial cell interactions","volume":"43","author":"Cid","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.004_bb0505","doi-asserted-by":"crossref","first-page":"R107","DOI":"10.1186\/ar3388","article-title":"Identification of target antigens of anti-endothelial cell and anti-vascular smooth muscle cell antibodies in patients with giant cell arteritis: a proteomic approach","volume":"13","author":"R\u00e9gent","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.autrev.2017.05.004_bb0510","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1136\/annrheumdis-2015-207846","article-title":"MicroRNA markers of inflammation and remodelling in temporal arteries from patients with giant cell arteritis","volume":"75","author":"Croci","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2017.05.004_bb0515","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/HYPERTENSIONAHA.115.05645","article-title":"Endogenous microRNAs in human microvascular endothelial cells regulate mRNAs encoded by hypertension-related genes","volume":"66","author":"Kriegel","year":"2015","journal-title":"Hypertension"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217301246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217301246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T08:03:56Z","timestamp":1692777836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997217301246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":103,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S1568997217301246"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2017.05.004","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New insights into the pathogenesis of giant cell arteritis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2017.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}